secwatch.observer — SEC 8-K summary
======================================

Issuer:     OSR Holdings, Inc. (OSRH)
CIK:        0001840425
Form:       8-K
Filed at:   2024-10-28T23:59:59+00:00
Accession:  0001193125-24-244725
Event type: debt
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bellevue Life Sciences advances $300K loan to OSR Holdings at 3.96% annual interest
--------------------------------------------------------------------------------

- Loan of $300,000 to OSR Holdings, target of proposed business combination, evidenced by promissory note.
- Interest rate 3.96% per annum, compound semi-annually; principal and interest due October 25, 2025.
- Funds to be used for working capital and other expenses of OSR Holdings.
- Default provisions include failure to pay within 5 business days of maturity and bankruptcy events.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840425/000119312524244725/0001193125-24-244725-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840425/000119312524244725/d889585d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-244725

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer